These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12069956)

  • 21. In vitro reversal of chloroquine resistance in Plasmodium falciparum with dihydroethanoanthracene derivatives.
    Pradines B; Alibert-Franco S; Houdoin C; Mosnier J; Santelli-Rouvier C; Papa V; Rogier C; Fusai T; Barbe J; Parzy D
    Am J Trop Med Hyg; 2002 Jun; 66(6):661-6. PubMed ID: 12224571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
    Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
    Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characteristics of the malaria parasite's "chloroquine resistance transporter": implications for chemotherapy.
    Summers RL; Martin RE
    Virulence; 2010; 1(4):304-8. PubMed ID: 21178460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
    Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
    Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
    Kalkanidis M; Klonis N; Tschan S; Deady LW; Tilley L
    Biochem Pharmacol; 2004 Apr; 67(7):1347-53. PubMed ID: 15013850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chloroquine accumulation by purified plasma membranes from Plasmodium falciparum.
    Elandaloussi LM; Smith PJ
    Chemotherapy; 2006; 52(1):50-2. PubMed ID: 16340201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between in vitro and in vivo antimalarial activity of compounds using CQ-sensitive and CQ-resistant strains of Plasmodium falciparum and CQ-resistant strain of P. yoelii.
    Srivastava K; Agarwal P; Soni A; Puri SK
    Parasitol Res; 2017 Jul; 116(7):1849-1854. PubMed ID: 28502016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action.
    Navarro M; Castro W; Madamet M; Amalvict R; Benoit N; Pradines B
    Malar J; 2014 Dec; 13():471. PubMed ID: 25470995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-aminoquinoline-triazine-based hybrids with improved in vitro antimalarial activity against CQ-sensitive and CQ-resistant strains of Plasmodium falciparum.
    Manohar S; Khan SI; Rawat DS
    Chem Biol Drug Des; 2013 May; 81(5):625-30. PubMed ID: 23331618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydroethanoanthracene derivatives reverse in vitro quinoline resistance in Plasmodium falciparum malaria.
    Henry M; Alibert S; Baragatti M; Mosnier J; Baret E; Amalvict R; Legrand E; Fusai T; Barbe J; Rogier C; Pagès JM; Pradines B
    Med Chem; 2008 Sep; 4(5):426-37. PubMed ID: 18782039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward a novel metal-based chemotherapy against tropical diseases. 7. Synthesis and in vitro antimalarial activity of new gold-chloroquine complexes.
    Navarro M; Vásquez F; Sánchez-Delgado RA; Pérez H; Sinou V; Schrével J
    J Med Chem; 2004 Oct; 47(21):5204-9. PubMed ID: 15456263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early transcriptional response to chloroquine of the Plasmodium falciparum antioxidant defence in sensitive and resistant clones.
    Nogueira F; Diez A; Radfar A; Pérez-Benavente S; do Rosario VE; Puyet A; Bautista JM
    Acta Trop; 2010 May; 114(2):109-15. PubMed ID: 20138820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
    Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
    ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum.
    Bray PG; Janneh O; Raynes KJ; Mungthin M; Ginsburg H; Ward SA
    J Cell Biol; 1999 Apr; 145(2):363-76. PubMed ID: 10209030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chloroquine transport via the malaria parasite's chloroquine resistance transporter.
    Martin RE; Marchetti RV; Cowan AI; Howitt SM; Bröer S; Kirk K
    Science; 2009 Sep; 325(5948):1680-2. PubMed ID: 19779197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, in vitro antimalarial activity and cytotoxicity of novel 4-aminoquinolinyl-chalcone amides.
    Smit FJ; N'da DD
    Bioorg Med Chem; 2014 Feb; 22(3):1128-38. PubMed ID: 24411478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of chloroquine resistance in Plasmodium falciparum using combinations of chemosensitizers.
    van Schalkwyk DA; Walden JC; Smith PJ
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3171-4. PubMed ID: 11600373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
    Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
    Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of piperaquine and other 4-aminoquinoline antiplasmodial drugs against chloroquine-sensitive and resistant blood-stages of Plasmodium falciparum. Role of beta-haematin inhibition and drug concentration in vacuolar water- and lipid-phases.
    Warhurst DC; Craig JC; Adagu IS; Guy RK; Madrid PB; Fivelman QL
    Biochem Pharmacol; 2007 Jun; 73(12):1910-26. PubMed ID: 17466277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.